Cargando…

Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission

BACKGROUND: Lymphatic filariasis (LF) is a mosquito-borne filarial disease targeted for elimination by the year 2020. The Republic of Togo undertook mass treatment of entire endemic communities from 2000 to 2009 to eliminate the transmission of the disease and is currently the first sub-Saharan Afri...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorkenoo, Monique A., de Souza, Dziedzom K., Apetogbo, Yao, Oboussoumi, Komla, Yehadji, Degninou, Tchalim, Mawèke, Etassoli, Santrao, Koudou, Benjamin, Ketoh, Guillaume K., Sodahlon, Yao, Bockarie, Moses J., Boakye, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781303/
https://www.ncbi.nlm.nih.gov/pubmed/29361964
http://dx.doi.org/10.1186/s13071-017-2611-9
_version_ 1783294924476645376
author Dorkenoo, Monique A.
de Souza, Dziedzom K.
Apetogbo, Yao
Oboussoumi, Komla
Yehadji, Degninou
Tchalim, Mawèke
Etassoli, Santrao
Koudou, Benjamin
Ketoh, Guillaume K.
Sodahlon, Yao
Bockarie, Moses J.
Boakye, Daniel A.
author_facet Dorkenoo, Monique A.
de Souza, Dziedzom K.
Apetogbo, Yao
Oboussoumi, Komla
Yehadji, Degninou
Tchalim, Mawèke
Etassoli, Santrao
Koudou, Benjamin
Ketoh, Guillaume K.
Sodahlon, Yao
Bockarie, Moses J.
Boakye, Daniel A.
author_sort Dorkenoo, Monique A.
collection PubMed
description BACKGROUND: Lymphatic filariasis (LF) is a mosquito-borne filarial disease targeted for elimination by the year 2020. The Republic of Togo undertook mass treatment of entire endemic communities from 2000 to 2009 to eliminate the transmission of the disease and is currently the first sub-Saharan African country to be validated by WHO for the elimination of LF as a public health problem. However, post-validation surveillance activities are required to ensure the gains achieved are sustained. This survey assessed the mosquito vectors of the disease and determined the presence of infection in these vectors, testing the hypothesis that transmission has already been interrupted in Togo. METHOD: Mosquitoes were collected from 37 villages located in three districts in one of four evaluation units in the country. In each district, 30 villages were selected based on probability proportionate to size; eight villages (including one of the 30 villages already selected) where microfilaremia-positive cases had been identified during post-treatment surveillance activities were intentionally sampled. Mosquitoes were collected using pyrethrum spray collections (PSC) in households randomly selected in all villages for five months. In the purposefully selected communities, mosquitoes were also collected using human landing collections (HLC) and exit traps (ET). Collected mosquitoes were identified morphologically, and the identification of Wuchereria bancrofti DNA in the mosquitoes was based on the pool screening method, using the LAMP assay. RESULTS: A total of 15,539 mosquitoes were collected during the study. Anopheles gambiae (72.6%) was the predominant LF vector collected using PSC. Pool screen analysis of 9191 An. gambiae in 629 pools revealed no mosquitoes infected with W. bancrofti (0%; CI: 0–0.021). CONCLUSIONS: These results confirm the findings of epidemiological transmission assessment surveys conducted in 2012 and 2015, which demonstrated the absence of LF transmission in Togo. The challenges of implementing molecular xenomonitoring are further discussed.
format Online
Article
Text
id pubmed-5781303
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57813032018-02-06 Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission Dorkenoo, Monique A. de Souza, Dziedzom K. Apetogbo, Yao Oboussoumi, Komla Yehadji, Degninou Tchalim, Mawèke Etassoli, Santrao Koudou, Benjamin Ketoh, Guillaume K. Sodahlon, Yao Bockarie, Moses J. Boakye, Daniel A. Parasit Vectors Research BACKGROUND: Lymphatic filariasis (LF) is a mosquito-borne filarial disease targeted for elimination by the year 2020. The Republic of Togo undertook mass treatment of entire endemic communities from 2000 to 2009 to eliminate the transmission of the disease and is currently the first sub-Saharan African country to be validated by WHO for the elimination of LF as a public health problem. However, post-validation surveillance activities are required to ensure the gains achieved are sustained. This survey assessed the mosquito vectors of the disease and determined the presence of infection in these vectors, testing the hypothesis that transmission has already been interrupted in Togo. METHOD: Mosquitoes were collected from 37 villages located in three districts in one of four evaluation units in the country. In each district, 30 villages were selected based on probability proportionate to size; eight villages (including one of the 30 villages already selected) where microfilaremia-positive cases had been identified during post-treatment surveillance activities were intentionally sampled. Mosquitoes were collected using pyrethrum spray collections (PSC) in households randomly selected in all villages for five months. In the purposefully selected communities, mosquitoes were also collected using human landing collections (HLC) and exit traps (ET). Collected mosquitoes were identified morphologically, and the identification of Wuchereria bancrofti DNA in the mosquitoes was based on the pool screening method, using the LAMP assay. RESULTS: A total of 15,539 mosquitoes were collected during the study. Anopheles gambiae (72.6%) was the predominant LF vector collected using PSC. Pool screen analysis of 9191 An. gambiae in 629 pools revealed no mosquitoes infected with W. bancrofti (0%; CI: 0–0.021). CONCLUSIONS: These results confirm the findings of epidemiological transmission assessment surveys conducted in 2012 and 2015, which demonstrated the absence of LF transmission in Togo. The challenges of implementing molecular xenomonitoring are further discussed. BioMed Central 2018-01-23 /pmc/articles/PMC5781303/ /pubmed/29361964 http://dx.doi.org/10.1186/s13071-017-2611-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Dorkenoo, Monique A.
de Souza, Dziedzom K.
Apetogbo, Yao
Oboussoumi, Komla
Yehadji, Degninou
Tchalim, Mawèke
Etassoli, Santrao
Koudou, Benjamin
Ketoh, Guillaume K.
Sodahlon, Yao
Bockarie, Moses J.
Boakye, Daniel A.
Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission
title Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission
title_full Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission
title_fullStr Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission
title_full_unstemmed Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission
title_short Molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in Togo: no evidence for active transmission
title_sort molecular xenomonitoring for post-validation surveillance of lymphatic filariasis in togo: no evidence for active transmission
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781303/
https://www.ncbi.nlm.nih.gov/pubmed/29361964
http://dx.doi.org/10.1186/s13071-017-2611-9
work_keys_str_mv AT dorkenoomoniquea molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission
AT desouzadziedzomk molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission
AT apetogboyao molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission
AT oboussoumikomla molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission
AT yehadjidegninou molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission
AT tchalimmaweke molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission
AT etassolisantrao molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission
AT koudoubenjamin molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission
AT ketohguillaumek molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission
AT sodahlonyao molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission
AT bockariemosesj molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission
AT boakyedaniela molecularxenomonitoringforpostvalidationsurveillanceoflymphaticfilariasisintogonoevidenceforactivetransmission